Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 2Unknown 1

Sponsor Class

OTHER 3INDUSTRY 2NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Gastrointestinal 1

Conditions

Precancerous Conditions 1Esophageal Neoplasms 1Barrett Esophagus 1Adenocarcinoma Of Esophagus 1

Interventions

Radiotherapy 106Cyclophosphamide 97Cisplatin 75Carboplatin 66Fluorouracil 64Etoposide 61Doxorubicin 60Chemotherapy, Adjuvant 60Vincristine 56Peripheral Blood Stem Cell Transplantation 48Filgrastim 47Paclitaxel 46Gemcitabine 44Cytarabine 41Neoadjuvant Therapy 40Leucovorin 40Docetaxel 35Melphalan 31Oxaliplatin 29Methotrexate 29Ifosfamide 25Gene Expression Profiling 25Amplified Fragment Length Polymorphism Analysis 24Immunohistochemistry 23Dexamethasone 22Irinotecan 21aldesleukin 20Prednisolone 20Interferon-alpha 20Tamoxifen 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × NIH × Endoscopy, Digestive System × Clear all
NCT00903136 2014-01-10

Tethered Capsule Endoscope in Screening Participants for Barrett Esophagus

National Cancer Institute (NCI)

Phase 1/2 Unknown
50 enrolled
GastrointestinalOther neoplasm

Adenocarcinoma Of Esophagus, Barrett Esophagus, Esophageal Neoplasms, Precancerous Conditions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡